VTI Launches the MyPath Education Initiative
The Path to Success in the Management of Myopia
Atlanta, Georgia, Monday, February 7, 2022: US-based medical device company and producer of the NaturalVue® Multifocal 1 Day Contact Lenses (‘NaturalVue MF’) Visioneering Technologies, Inc (ASX: VTI) (‘Visioneering’, ‘VTI’ or ‘the Company’) launched the MyPath Education Initiative at the recently held GSLS event in Las Vegas, Nevada.
MyPath is a new initiative from VTI designed to support the success of eye care practitioners in the management of myopia. It’s one place for a host of resources and tools to move the myopia practice forward.
VTI has curated content in a variety of categories, including questionnaires, articles, webinars, scripts, helpful websites, efficacy data, and sales materials to help you manage the disease of Myopia.
Practice success begins with the MyPath Accreditation. The accreditation process expands your knowledge and offers progress toward more effectively serving the next generation of myopes. VTI has created a series of short, customized courses with practical information to help both ECP and staff understand the essentials of myopia management in practice.
The MyPath Resource Hub is one place for the educational resources and tools that Eye Care Practitioners need to move their myopia practices forward. Taking part in the MyPath initiative helps ECP’s more effectively:
- Prepare the practice to become a center of excellence in the management of myopia
- Execute the consultation, from patient selection to intervention
- Manage the myopia practice, from exam room equipment to fee structure
This initiative comes on the heels of the newly launched NaturalVue® (etafilcon A) Enhanced Multifocal 1 Day™ contact lenses with new comfort enhancements. With the TripleTear® lubrication system and new Ultra-Tapered Edge, wearers of all ages start comfortable and stay comfortable1. This new product can go far to better manage presbyopia.
“VTI is dedicated to battling the global scourge of myopia, and proud to introduce the MyPath initiative to serve as a resource for eye care professionals”, said Tony Sommer, Senior Vice-President, Sales & Marketing for VTI. “The MyPath initiative, with its educational and in-office resources, can help ECPs succeed with the management of myopia in their practices.”
Eye care practitioners may access the MyPath hub at https://vtivision.com/practitioner/mypath/. For more information, contact firstname.lastname@example.org.
About Visioneering Technologies
Visioneering Technologies Inc. (ASX: VTI) is an innovative eye care company committed to redefining vision. Since its founding in 2008, Visioneering has brought together clinical, marketing, engineering, manufacturing, and regulatory leaders from top vision care businesses to provide new solutions for presbyopia, myopia, and astigmatism.
Headquartered in the US, Visioneering designs, manufactures, sells, and distributes contact lenses. Its flagship product is the NaturalVue® Multifocal contact lens, and VTI has expanded its portfolio of technologies to address a range of eye care issues. The company has grown operations across the United States, Australia, and Europe and is expanding into Asia with a focus on markets with high rates of myopia.
- VTI data on file, 2021. N=53.
NATURALVUE ENHANCED INDICATIONS FOR USE
NaturalVue® (etafilcon A) Enhanced Multifocal 1 Day™ Disposable Soft Contact Lenses are indicated for daily wear for the correction of refractive ametropia (myopia and hyperopia), and/or presbyopia in normal eyes.
NATURALVUE SPHERE INDICATIONS FOR USE
NaturalVue® (etafilcon A) Enhanced Sphere 1 Day™ Disposable Soft Contact Lenses are indicated for daily wear for the correction of refractive ametropia (myopia and hyperopia) in normal eyes.